Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENOCHIAN BIOSCIENCES, INC.

(ENOB)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/14/2021 09/15/2021 09/16/2021 09/17/2021 09/20/2021 Date
7.14(c) 7.02(c) 7.29(c) 7.25(c) 6.8699 Last
214 967 314 356 198 441 236 836 134 142 Volume
-5.68% -1.68% +3.85% -0.55% -5.24% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 - - -
Net income 2019 -18,0 M - -
Net cash position 2019 12,3 M - -
P/E ratio 2019 -9,38x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -11,4 M - -
Net cash position 2020 1,11 M - -
P/E ratio 2020 -17,1x
Yield 2020 -
Capitalization 377 M 377 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 10
Free-Float 38,2%
More Financials
Company
Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic... 
More about the company
All news about ENOCHIAN BIOSCIENCES, INC.
09/13ENOCHIAN BIOSCIENCES INC : Regulation FD Disclosure, Financial Statements and Ex..
AQ
09/13ENOCHIAN BIOSCIENCES : Slide Presentation Here
PU
09/13ENOCHIAN BIOSCIENCES : to Present to Investors at the H.C. Wainwright 23rd Annua..
AQ
08/30ENOCHIAN BIOSCIENCES : Distinguished Scientific and Public Health Leaders to Joi..
PU
08/30ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form..
AQ
08/30ENOCHIAN BIOSCIENCES : Distinguished Scientific and Public Health Leaders to Joi..
AQ
08/30Enochian Biosciences, Inc. Appoints Dr. Peter Piot and Dr. Richard Whitley to..
CI
08/23Dr. Anna Suk-Fong Lok, Md to Joins Enochian Biosciences’ Hepatitis B Cure Sci..
CI
08/23ENOCHIAN BIOSCIENCES : Distinguished Scientific and Clinical Leader to Join Enoc..
PU
08/16ENOCHIAN BIOSCIENCES : Entry into a Material Definitive Agreement, Financial Sta..
AQ
07/23ENOCHIAN BIOSCIENCES : Names The Hon. Dr. Mark Dybul as Chief Executive Officer ..
PU
07/23ENOCHIAN BIOSCIENCES INC : Entry into a Material Definitive Agreement, Regulatio..
AQ
07/20ENOCHIAN BIOSCIENCES : Appoints Mark Dybul as CEO
MT
07/20ENOCHIAN BIOSCIENCES : Names The Hon. Dr. Mark Dybul as Chief Executive Officer
AQ
07/20Enochian BioSciences Names the Hon. Dr. Mark Dybul as Chief Executive Officer
CI
More news
News in other languages on ENOCHIAN BIOSCIENCES, INC.
05/14Enochian BioSciences kondigt een wetenschappelijke presentatie aan van een pe..
More news
Chart ENOCHIAN BIOSCIENCES, INC.
Duration : Period :
Enochian Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENOCHIAN BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Mark Richard Dybul Executive Vice Chairman & Chief Executive Officer
Luisa Puche Chief Financial Officer
Rene Sindlev Chairman
Joseph R. Cohen Director-Research & Discovery
Carl Sandler Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENOCHIAN BIOSCIENCES, INC.145.76%377
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850